HPAPIs (Highly Potent APIs)

Mastery of the Potent Frontier: Secure Your HPAPI & ADC Pipeline

HPAPIs (Highly Potent APIs)

India's HPAPI ecosystem is world-class, but navigating it demands more than capacity claims. Hidden risks - from inconsistent maintenance cultures to ultra-trace cross-contamination - separate successful programs from costly failures.

Aventiq Bio acts as your sentinel: independent, on-ground, and technically rigorous.

The Hidden Risks That Derail HPAPI Programs

Shadow Capacity Claims:

Many facilities advertise OEB 5 but lack sustained maintenance cultures, leading to gradual containment degradation
Ultra-Trace Detection Failures:

Standard analytics miss low-ppm contamination, causing batch rejections or recalls
Waste Stream Liability:

Increasing global scrutiny on toxic waste handling in emerging markets - exposing sponsors to reputational and legal risk
Tech Transfer Fragility:

Potent charging/discharging phases prone to exposure during scale-up.
Regulatory Ambush:

Heightened focus on Category 4–5 compounds resulting in 483s, import alerts, or delayed approvals.

The Aventiq Sentinel: Functional Oversight for Zero-Error HPAPI Programs

The HPAPI Life-Cycle Guard – Our Functional Oversight

Partner Vetting Extreme Containment Due Diligence

Beyond paper audits: Verification of isolator integrity, pressure logs, and cleaning validation history

Tech Transfer Cross-Contamination Mapping

Custom cleaning validation strategies to prevent ppm-level carryover

Analytical Ultra-Trace Method Governance

Oversight of specialized methods (LC-MS, ICP-MS) for sub-ppm detection

On-Ground The Sentinel (Person-in-Plant)

Dedicated oversight during high-risk phases (charging, sampling, discharging)

Potent Peptides Support

Potent Peptide Synthesis Oversight

Contained solid-phase synthesis for cytotoxic or high-potency peptides

Scale-Up & Analytical:

Impurity control for potent sequences (deletion, racemization)

Integration with ADC/Oncology

Peptide payloads or cleavable linkers for conjugates under extreme containment

The Aventiq Edge : Bridging HPAPIs with peptide programs – critical for next generation oncology

Why Aventiq Bio – The Sentinel Difference

India's HPAPI capacity is competitive, but capacity claims alone do not equal sustained containment performance. Aventiq Bio acts as your independent sentinel — verifying true OEB 4–5 capability, protecting potent IP, and enforcing zero-exposure and waste-stream accountability so sponsors can access cost and capacity advantages with Western-level safety and regulatory confidence.

What sets us apart:

Proprietary intelligence on truly maintenance-verified OEB 5-capable facilities — not brochure claims
On-ground sentinel teams with deep experience in isolator integrity, pressure differentials, and potent charging/discharge operations
Ultra-trace analytical method governance (LC-MS / ICP-MS) and predictive containment & waste-liability risk models
True independence — we own no laboratories, accept zero vendor commissions, and act solely as your firewall
Full ALCOA+ data integrity and waste-stream accountability that meets FDA / EMA expectations

Aventiq Bio enforces zero-exposure protocols and delivers Western-executive confidence in every potent program.

HPAPIs (Highly Potent APIs)